Monthly Archives: November 2015

Four pegylated drugs approved by FDA in the last five years

Plegridy (Biogen 2014) — PEGylated Interferon Beta-1a for the treatment of patients with relapsing forms of multiple sclerosis. Naloxegol (Movantik) (AstraZeneca 2014) — PEGylated naloxol for the treatment of opioid-induced constipation in adults patients with chronic non-cancer pain. Pegnesatide (Omontys) … Continue reading

Posted in Blogs | 1 Comment